Delhi University approves financial support of up to ₹17 crore for the 9-month-old daughter of a SOL teacher, who has been diagnosed with spinal muscular atrophy type II, a rare genetic disorder. The treatment is described as an expensive, one-time gene therapy intended to prevent further disease progression.

The university responds to the urgency by setting up a committee headed by the Vice-Chancellor to examine funding options. While both outlets report the same approval amount and medical context, their framing differs: the Times of India focuses on the immediate approval and the committee’s role in identifying how to meet urgent needs, whereas The Hindu leads with the aid figure and the child’s condition as the central fact.